mouse anti rat wilms tumor 1 wt 1 Search Results


99
NSJ Bioreagents wt1 antibody / wilms tumor 1
Wt1 Antibody / Wilms Tumor 1, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt1 antibody / wilms tumor 1/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
wt1 antibody / wilms tumor 1 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
Boster Bio wilms tumor 1 wt1
Antibodies used in this study.
Wilms Tumor 1 Wt1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wilms tumor 1 wt1/product/Boster Bio
Average 90 stars, based on 1 article reviews
wilms tumor 1 wt1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Thermo Fisher gene exp wt1 mm01337048 m1
Antibodies used in this study.
Gene Exp Wt1 Mm01337048 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp wt1 mm01337048 m1/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
gene exp wt1 mm01337048 m1 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

95
Proteintech wt1
Antibodies used in this study.
Wt1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt1/product/Proteintech
Average 95 stars, based on 1 article reviews
wt1 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology tumor 1 wt1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Tumor 1 Wt1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor 1 wt1/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
tumor 1 wt1 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

98
Thermo Fisher gene exp wt1 hs01103751 m1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Gene Exp Wt1 Hs01103751 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp wt1 hs01103751 m1/product/Thermo Fisher
Average 98 stars, based on 1 article reviews
gene exp wt1 hs01103751 m1 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc tumor 1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Tumor 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tumor 1/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
tumor 1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

88
Thermo Fisher gene exp pax2 hs01057416 m1
Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing <t>WT1</t> + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.
Gene Exp Pax2 Hs01057416 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp pax2 hs01057416 m1/product/Thermo Fisher
Average 88 stars, based on 1 article reviews
gene exp pax2 hs01057416 m1 - by Bioz Stars, 2026-05
88/100 stars
  Buy from Supplier

91
Novus Biologicals wt1
Absence of hTERT expression in TG20 ALT cells. ( a ) hTERT mRNA expression in telomerase-positive GSCs (TG16, TG1N, OB1 and TG10) and ALT cells (TG20 and SAOS-2). Values are presented as the mean ± SEM of two independent experiments performed in duplicate. ( b ) The same cell lines as in ( a ) were evaluated but for hTERC mRNA expression. ( c ) Representative methylation-specific PCR (MSP) results for the proximal region and <t>WT1</t> binding site of the TERT promoter in SAOS-2 and TG20 ALT cells and in TG1N and TG16 telomerase-positive cells. Bands in the M and U lanes represent methylated and unmethylated PCR products, respectively. ( d ) mRNA expression of hTERT, TES, and RUNX3 in TG20 cells after treatment with 2.5 or 5 µM 5-azacytidine (5-aza), relative to their expression in control DMSO-treated cells. ( e ) WT1 protein levels determined by Western blot analysis for the indicated cell lines. β-Actin was used as a loading control. ( f ) Comparison of expression ratios of WT1 protein vs . β-actin in the different cell lines. Experiment was repeated twice using samples from independent cell cultures.
Wt1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wt1/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
wt1 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

90
Nordic BioSite anti-wilms tumor 1 (wt-1)
Absence of hTERT expression in TG20 ALT cells. ( a ) hTERT mRNA expression in telomerase-positive GSCs (TG16, TG1N, OB1 and TG10) and ALT cells (TG20 and SAOS-2). Values are presented as the mean ± SEM of two independent experiments performed in duplicate. ( b ) The same cell lines as in ( a ) were evaluated but for hTERC mRNA expression. ( c ) Representative methylation-specific PCR (MSP) results for the proximal region and <t>WT1</t> binding site of the TERT promoter in SAOS-2 and TG20 ALT cells and in TG1N and TG16 telomerase-positive cells. Bands in the M and U lanes represent methylated and unmethylated PCR products, respectively. ( d ) mRNA expression of hTERT, TES, and RUNX3 in TG20 cells after treatment with 2.5 or 5 µM 5-azacytidine (5-aza), relative to their expression in control DMSO-treated cells. ( e ) WT1 protein levels determined by Western blot analysis for the indicated cell lines. β-Actin was used as a loading control. ( f ) Comparison of expression ratios of WT1 protein vs . β-actin in the different cell lines. Experiment was repeated twice using samples from independent cell cultures.
Anti Wilms Tumor 1 (Wt 1), supplied by Nordic BioSite, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-wilms tumor 1 (wt-1)/product/Nordic BioSite
Average 90 stars, based on 1 article reviews
anti-wilms tumor 1 (wt-1) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

99
NSJ Bioreagents epcam antibody
Absence of hTERT expression in TG20 ALT cells. ( a ) hTERT mRNA expression in telomerase-positive GSCs (TG16, TG1N, OB1 and TG10) and ALT cells (TG20 and SAOS-2). Values are presented as the mean ± SEM of two independent experiments performed in duplicate. ( b ) The same cell lines as in ( a ) were evaluated but for hTERC mRNA expression. ( c ) Representative methylation-specific PCR (MSP) results for the proximal region and <t>WT1</t> binding site of the TERT promoter in SAOS-2 and TG20 ALT cells and in TG1N and TG16 telomerase-positive cells. Bands in the M and U lanes represent methylated and unmethylated PCR products, respectively. ( d ) mRNA expression of hTERT, TES, and RUNX3 in TG20 cells after treatment with 2.5 or 5 µM 5-azacytidine (5-aza), relative to their expression in control DMSO-treated cells. ( e ) WT1 protein levels determined by Western blot analysis for the indicated cell lines. β-Actin was used as a loading control. ( f ) Comparison of expression ratios of WT1 protein vs . β-actin in the different cell lines. Experiment was repeated twice using samples from independent cell cultures.
Epcam Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epcam antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
epcam antibody - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology rac 1 protein
Absence of hTERT expression in TG20 ALT cells. ( a ) hTERT mRNA expression in telomerase-positive GSCs (TG16, TG1N, OB1 and TG10) and ALT cells (TG20 and SAOS-2). Values are presented as the mean ± SEM of two independent experiments performed in duplicate. ( b ) The same cell lines as in ( a ) were evaluated but for hTERC mRNA expression. ( c ) Representative methylation-specific PCR (MSP) results for the proximal region and <t>WT1</t> binding site of the TERT promoter in SAOS-2 and TG20 ALT cells and in TG1N and TG16 telomerase-positive cells. Bands in the M and U lanes represent methylated and unmethylated PCR products, respectively. ( d ) mRNA expression of hTERT, TES, and RUNX3 in TG20 cells after treatment with 2.5 or 5 µM 5-azacytidine (5-aza), relative to their expression in control DMSO-treated cells. ( e ) WT1 protein levels determined by Western blot analysis for the indicated cell lines. β-Actin was used as a loading control. ( f ) Comparison of expression ratios of WT1 protein vs . β-actin in the different cell lines. Experiment was repeated twice using samples from independent cell cultures.
Rac 1 Protein, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rac 1 protein/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
rac 1 protein - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

Image Search Results


Antibodies used in this study.

Journal: Molecular Metabolism

Article Title: P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response

doi: 10.1016/j.molmet.2020.101089

Figure Lengend Snippet: Antibodies used in this study.

Article Snippet: Wilms Tumor-1 (WT1) , Boster Biological Technology , #M00199-1 , Rabbit , 1 μg/ml (IHC).

Techniques:

P2Y2R deficiency protects against podocyte loss and glomerular injury in DN. (A) Relative mRNA levels of Nphs1 (nephrin) and Nphs2 (podocin) were determined by real-time PCR analysis (n = 3–5). (B) Localisation of WT1, a podocyte marker, was analysed by immunohistochemistry, and representative images are shown. The number of stained podocytes per glomeruli was counted by using ImageJ software (n = 3). (C) Kidney sections were stained with PAS staining and glomerular morphological changes were scored as described in the method section (n = 3). Data are presented as mean ± SEM. One-way ANOVA was used for statistical analysis followed by Bonferroni's multiple comparisons test. ∗∗∗p < 0.001 vs WT control mice; and ### p < 0.001 vs WT DN mice. Scale bar, 50 μm.

Journal: Molecular Metabolism

Article Title: P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response

doi: 10.1016/j.molmet.2020.101089

Figure Lengend Snippet: P2Y2R deficiency protects against podocyte loss and glomerular injury in DN. (A) Relative mRNA levels of Nphs1 (nephrin) and Nphs2 (podocin) were determined by real-time PCR analysis (n = 3–5). (B) Localisation of WT1, a podocyte marker, was analysed by immunohistochemistry, and representative images are shown. The number of stained podocytes per glomeruli was counted by using ImageJ software (n = 3). (C) Kidney sections were stained with PAS staining and glomerular morphological changes were scored as described in the method section (n = 3). Data are presented as mean ± SEM. One-way ANOVA was used for statistical analysis followed by Bonferroni's multiple comparisons test. ∗∗∗p < 0.001 vs WT control mice; and ### p < 0.001 vs WT DN mice. Scale bar, 50 μm.

Article Snippet: Wilms Tumor-1 (WT1) , Boster Biological Technology , #M00199-1 , Rabbit , 1 μg/ml (IHC).

Techniques: Real-time Polymerase Chain Reaction, Marker, Immunohistochemistry, Staining, Software, Control

Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing WT1 + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.

Journal: Physiological Reports

Article Title: Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival

doi: 10.14814/phy2.12537

Figure Lengend Snippet: Mesangial defects in FoxD1 GC ;Dicer fl/fl mature glomeruli at E18.5. (A–D) Immunofluorescence staining for Desmin (red) showed evidence for early mesangial cell migration in both control ( n = 3 embryos, 25 comma-/s-shaped bodies) and FoxD1 GC ;Dicer fl/fl ( n = 3 embryos, 16 comma-/s-shaped bodies) developing WT1 + (red) comma- and s-shaped bodies. (E, F) Developing capillary loop nephrons as marked by expression of Lef1 (red) in early podocytes showed evidence for Pdgfr β + (green) mesangial formation in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 49 glomeruli), although the mesangial network appeared simplified when compared to controls ( n = 3 embryos, 52 glomeruli). (G–L) Mature FoxD1 GC ;Dicer fl/fl glomeruli displayed overt mesangial abnormalities as evident by a significant reduction in Pdgfr β + (green) and Desmin + (red) immunoreactivity. (M–O) Semiquantitative analysis revealed no significant difference in developing WT1 + comma- and s-shaped bodies (M) or Lef1 + early glomeruli (N) in control and FoxD1 GC ;Dicer fl/fl embryos. However, there were significantly fewer WT1 + mature glomeruli with a Desmin + mesangial network in FoxD1 GC ;Dicer fl/fl kidneys ( n = 3 embryos, 29 glomeruli, **** P < 0.0001), when compared to controls ( n = 3 embryos, 19 glomeruli) (O). The presence of WT1 + (red) podocytes and intussuscepted Pecam + (red) capillaries in the FoxD1 GC ;Dicer fl/fl glomeruli suggest that the mesangial defects are likely to be a primary consequence of loss of stromal miRNAs.

Article Snippet: Primary antibodies were used at 1:100 dilution and include: Six2 (Proteintech #11562-1-AP, Chicago, IL), Forkhead box D1 (FoxD1) (Santa Cruz #sc-47585, Dallas, TX), Calbindin (Sigma #C9848, St. Louis, MO), annexin A2 (Anxa2) (Cell Signaling #8235, Danvers, MA), Neural cell adhesion molecule (Ncam) (Sigma #C9672), Tenascin C (Millipore #AB19011, Billerica, MA), Yes-associated protein 1 (Yap) (Cell Signaling #4912), phospho-Yap (pYap) (Cell Signaling #4911), Desmin (Dako #M076029-2, Carpinteria, CA), Wilm’s tumor-1 (WT1) (Santa Cruz #sc-192), Platelet-derived growth factor receptor- β (Pdgfr β ) (eBiosciences, Millipore #14-1402), α -smooth muscle actin (SMA)-FITC (Sigma #F3777), Renin (Santa Cruz #sc-27318), Lef1 (Cell Signaling #2230), Pecam (BD Pharmingen #BDB550274, San Jose, CA), Bcl2-like 11 (Bim) (Cell Signaling #2819), Meis1/2/3 (Millipore #05-779), aCaspase3 (Promega #PRG7481, Madison, WI), and phospho-histone H3 (Sigma #H9161).

Techniques: Immunofluorescence, Staining, Migration, Control, Expressing

Absence of hTERT expression in TG20 ALT cells. ( a ) hTERT mRNA expression in telomerase-positive GSCs (TG16, TG1N, OB1 and TG10) and ALT cells (TG20 and SAOS-2). Values are presented as the mean ± SEM of two independent experiments performed in duplicate. ( b ) The same cell lines as in ( a ) were evaluated but for hTERC mRNA expression. ( c ) Representative methylation-specific PCR (MSP) results for the proximal region and WT1 binding site of the TERT promoter in SAOS-2 and TG20 ALT cells and in TG1N and TG16 telomerase-positive cells. Bands in the M and U lanes represent methylated and unmethylated PCR products, respectively. ( d ) mRNA expression of hTERT, TES, and RUNX3 in TG20 cells after treatment with 2.5 or 5 µM 5-azacytidine (5-aza), relative to their expression in control DMSO-treated cells. ( e ) WT1 protein levels determined by Western blot analysis for the indicated cell lines. β-Actin was used as a loading control. ( f ) Comparison of expression ratios of WT1 protein vs . β-actin in the different cell lines. Experiment was repeated twice using samples from independent cell cultures.

Journal: International Journal of Cancer. Journal International du Cancer

Article Title: A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)

doi: 10.1002/ijc.29171

Figure Lengend Snippet: Absence of hTERT expression in TG20 ALT cells. ( a ) hTERT mRNA expression in telomerase-positive GSCs (TG16, TG1N, OB1 and TG10) and ALT cells (TG20 and SAOS-2). Values are presented as the mean ± SEM of two independent experiments performed in duplicate. ( b ) The same cell lines as in ( a ) were evaluated but for hTERC mRNA expression. ( c ) Representative methylation-specific PCR (MSP) results for the proximal region and WT1 binding site of the TERT promoter in SAOS-2 and TG20 ALT cells and in TG1N and TG16 telomerase-positive cells. Bands in the M and U lanes represent methylated and unmethylated PCR products, respectively. ( d ) mRNA expression of hTERT, TES, and RUNX3 in TG20 cells after treatment with 2.5 or 5 µM 5-azacytidine (5-aza), relative to their expression in control DMSO-treated cells. ( e ) WT1 protein levels determined by Western blot analysis for the indicated cell lines. β-Actin was used as a loading control. ( f ) Comparison of expression ratios of WT1 protein vs . β-actin in the different cell lines. Experiment was repeated twice using samples from independent cell cultures.

Article Snippet: WT1 (Wilm's tumor protein 1) antibody (1:400, NB-110–60011; Novus Biologicals) was used to detect the WT1 protein.

Techniques: Expressing, Methylation, Binding Assay, Control, Western Blot, Comparison